IN VITRO METHOD FOR QUANTIFYING THE CELLULAR CONTENT OF SPECIFIC RNAS

Patent number:

PCT/EP2022/068795

Comunidad de Madrid.svg
No items found.

The present invention refers to an in vitro method for quantifying total cell RNA content, preferably total cell content of long-non-coding RNAs (lncRNA), more preferably total cell content of lncRNA molecules transcribed from telomeric or sub-telomeric sequences or present in telomeric regions, such as TERRA and/or TERC.

Countries:
Spain
Regions:
Community of Madrid
Centers:
UNIVERSIDAD AUTONOMA DE MADRID
Other entities:
Sectors:
Health
Subsectors:
TRL Level:
TRL 4 – technology validated in lab
BRL Level:
PDF Link:
Download here
Video Link:
Watch it here
Sustainable Development Goal:
SDG03: Good health and well-being
Applications

The invention refers to an in vitro method for quantifying the cellular content of a given RNA in a size independent manner. Specifically, the cellular content of long-non-coding RNA (lncRNAs), preferably total cellular content of lncRNA molecules transcribed from telomeric or sub-telomeric sequences, or present in telomeric regions, such as TERRA and/or TERC, can be quantified according to the present invention. It can be applied in biomedical field.

Comments

Other related patents

Health

A NEW BIOMARKER EXPRESSED IN PANCREATIC BETA CELLS USEFUL IN IMAGING OR TARGETING BETA CELLS

Countries
Belgium
Know more
Food & Agro
Health

Minimal miRNA precursors

Countries
Spain
Know more
Health

UTERINE MANIPULATOR FOR MINIMALLY INVASIVE SURGERY

Countries
Spain
Know more
Get back to patents directory